Clinical Study
Cancers in Togo from 1984 to 2008: Epidemiological and Pathological Aspects of 5251 Cases
Table 4
Distribution of cancers by histological nature.
| | Histological group | Histological type | Nb** of cases | % |
| | Carcinomas 3574 cases; 68,1% | Adenocarcinomas | 2099 | 40.0 | | Squamous cell carcinoma | 1238 | 23.6 | | Carcinoma NOS* | 155 | 2.9 | | Urothelial carcinoma | 35 | 0.6 | | Medullar carcino ma | 31 | 0.6 | | Basaloid carcinoma | 19 | 0.4 | | Hematopoietic tissue Cancers 833 cases; 15.9% | Non-hodgkin lymphoma | 663 | 12.6 | | Hodgkin disease | 97 | 1.9 | | Leukaemia | 58 | 1.1 | | Myeloma | 15 | 0.3 | | Sarcomas 581 cases; 11.0% | Kaposi sarcoma | 225 | 4.3 | | Fibrosarcoma | 146 | 2.8 | | Leiomyosarcoma | 38 | 0.7 | | Rhabdomyosarcoma | 35 | 0.6 | | Osteosarcoma | 30 | 0.5 | | Chondrosarcoma | 28 | 0.5 | | Liposarcoma | 27 | 0.5 | | Angiosarcoma | 19 | 0.4 | | Malignant fibrous histiocytoma | 19 | 0.4 | | Ewing sarcoma | 4 | 0.1 | | Sarcoma NOS* | 10 | 0.2 | | Embryonic and placental malignant tumors 143 cases; 2.7% | Choriocarcinoma | 50 | 1.0 | | Retinoblastoma | 38 | 0.7 | | Wilms tumor | 19 | 0.4 | | Malignant teratoma | 10 | 0.2 | | Yolk sac tumor | 6 | 0.1 | | Hepatoblastoma | 5 | 0.1 | | Seminoma | 5 | 0.1 | | Glioblastoma | 5 | 0.1 | | Gonadoblastoma | 3 | 0.0 | | Other | 2 | 0.0 | | Other specified cancers 120 cases; 2.3% | Melanoma | 83 | 1.6 | | Granulosa tumor | 19 | 0.4 | | Mesothelioma | 7 | 0.1 | | Malignant schwannoma | 8 | 0.2 | | Carcinosarcoma | 3 | 0.0 |
| | All | 5251 | 100 |
|
|
*NOS: not otherwise specified. **Nb: Nomber.
|